Viking Therapeutics
VKTX
$76.97
Share price
1.60%
Change (1 day)
255.19%
Change (1 year)
Categories
Viking Therapeutics (VKTX) Fails to deliver data
Key failure to deliver metrics for Viking Therapeutics :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $5.99 M
- Last 3 months FTD volume: $62.78 M
- Last year FTD volume: $77.63 M
Failures to deliver for Viking Therapeutics (VKTX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Viking Therapeutics (VKTX) - since 2015
Volume in USD (price x number of shares), data since 2015Viking Therapeutics (VKTX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $65.08 M | 158.41% |
| 2023 | $25.18 M | 24.99% |
| 2022 | $20.15 M | 145.72% |
| 2021 | $8.2 M | -67.32% |
| 2020 | $25.09 M | -64.2% |
| 2019 | $70.1 M | 65.69% |
| 2018 | $42.3 M | 1260.66% |
| 2017 | $3.1 M | -27.57% |
| 2016 | $4.29 M | 374.79% |
| 2015 | $0.9 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Ultragenyx RARE | $3.36 M | $14.94 M | 🇺🇸 USA |
 Repligen
RGEN | $8.48 M | $0.10 B | 🇺🇸 USA |